New Cell-Based Technology by Cytonus Aims to Revolutionize the Fight against Cancer and Inflammatory Diseases

SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics Inc. announced today that it has developed Cargocytes™ a first-of-its-kind, controllable, cell-based platform technology for delivery of biologics. Cargocytes are engineered allogenic cell lines that can carry a variety of payloads like small molecule compounds, gene editing therapies, therapeutic RNAs, and powerful biologics such as immune modulating cytokines, antibodies and oncolytic viruses. “Our technology revolutionizes the ability of cells

Click to view original post